logo
Risk factors and stroke risk stratification for atrial fibrillation
Evaluating diagnostic tests—should the same methods apply?
Late-breaking trials summary from the 2008 American College of Cardiology Scientific Sessions, March 29 to April 1, Chicago, IL
Body mass index and mortality in heart failure
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events
Rationale and design of the Post-MI FREEE trial
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy
The Harmonizing Outcomes with RevascularIZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial
Chronic atrial fibrillation
Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker
N-terminal pro-brain natriuretic peptide testing in the emergency department
Impact of do-not-resuscitation orders on quality of care performance measures in patients hospitalized with acute heart failure
Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy
Potential role of antibodies against cardiac Kv channel-interacting protein 2 in dilated cardiomyopathy
Exercise capacity and biventricular function in adult patients with repaired tetralogy of Fallot
An assessment of the joint associations of aspirin and statin use with C-reactive protein concentration
Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities
Thrombocytopenia at baseline is a predictor of inhospital mortality in patients undergoing percutaneous coronary intervention
Safety and effectiveness of drug-eluting stents among diabetic patients
One-year clinical outcome after abciximab bolus-only compared with abciximab bolus and 12-hour infusion in the Randomized EArly Discharge after Transradial Stenting of CoronarY Arteries (EASY) Study
Correlates of late and very late thrombosis of drug eluting stents
Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial
Do specialty cardiac hospitals have greater adherence to acute myocardial infarction and heart failure process measures? An empirical assessment using Medicare quality measures
Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy
Factors that influence the use of ambulance in acute coronary syndrome
Smoking status and antithrombin therapy in patients with non-ST-segment elevation acute coronary syndrome
Patterns of transfer for patients with non-ST-segment elevation acute coronary syndrome from community to tertiary care hospitals
Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome
Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?
Recovery of normal ventricular function in patients with dilated cardiomyopathy
Obesity and postoperative atrial fibrillation. Is there no connection?